Literature DB >> 9188581

Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR.

M T Dittmar1, G Simmons, Y Donaldson, P Simmonds, P R Clapham, T F Schulz, R A Weiss.   

Abstract

In order to characterize the biological properties of human immunodeficiency virus type 1 (HIV-1) variants from different tissues (peripheral blood mononuclear cells [PBMC], lymph node, spleen, brain, and lung) of one patient, we have chosen long-range PCR to amplify virtually full-length HIV proviruses and to construct replication-competent viruses by adding a patient-specific 5' long terminal repeat. To avoid selection during propagation in CD4+ target cells, we transfected 293 cells and used the supernatants from these cells as challenge viruses for tropism studies after titration on human PBMC. Despite differences in the V3 loop of the major variants found in brain and lung compared to lymphoid tissues all recombinant HIV clones obtained showed identical cell tropism and replicative kinetics. After infection of human PBMC these viruses replicated with similar kinetics, with a slow/low-titer, non-syncytium-inducing phenotype. In contrast to the prediction of macrophage tropism, drawn from the V3 loop sequence, none of these viruses infected monocyte-derived macrophages. The challenge of blood dendritic cells by these recombinant viruses in the presence of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and interleukin-4 resulted in a productive infection only after adding stimulated CD4+ T lymphocytes. Therefore, the biological properties of the HIV-1 variants derived from nonlymphoid tissue of this patient did not differ from those of HIV-1 variants from lymphoid tissue with respect to tropism for primary cells such as PBMC, macrophages, and blood dendritic cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188581      PMCID: PMC191749          DOI: 10.1128/JVI.71.7.5140-5147.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Long polymerase chain reaction amplification of heterogeneous HIV type 1 templates produces recombination at a relatively high frequency.

Authors:  Y L Yang; G Wang; K Dorman; A H Kaplan
Journal:  AIDS Res Hum Retroviruses       Date:  1996-03-01       Impact factor: 2.205

2.  Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus.

Authors:  P R Clapham; D Blanc; R A Weiss
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

3.  Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene.

Authors:  Y Takeuchi; M Akutsu; K Murayama; N Shimizu; H Hoshino
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

4.  Molecular cloning of full-length HIV-1 genomes directly from plasma viral RNA.

Authors:  G Fang; B Weiser; A A Visosky; L Townsend; H Burger
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-08-01

5.  Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand.

Authors:  J K Carr; M O Salminen; C Koch; D Gotte; A W Artenstein; P A Hegerich; D St Louis; D S Burke; F E McCutchan
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

6.  Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.

Authors:  G Simmons; D Wilkinson; J D Reeves; M T Dittmar; S Beddows; J Weber; G Carnegie; U Desselberger; P W Gray; R A Weiss; P R Clapham
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

7.  Characterization of human immunodeficiency virus type 1 strains recovered from the bowel of infected individuals.

Authors:  S W Barnett; A Barboza; C M Wilcox; C E Forsmark; J A Levy
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

8.  Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis.

Authors:  P Simmonds; L Q Zhang; F McOmish; P Balfe; C A Ludlam; A J Brown
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

Authors:  S S Hwang; T J Boyle; H K Lyerly; B R Cullen
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

10.  Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene.

Authors:  T Shioda; J A Levy; C Cheng-Mayer
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

View more
  18 in total

1.  Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana.

Authors:  V A Novitsky; M A Montano; M F McLane; B Renjifo; F Vannberg; B T Foley; T P Ndung'u; M Rahman; M J Makhema; R Marlink; M Essex
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Distinct human immunodeficiency virus strains in the bone marrow are associated with the development of thrombocytopenia.

Authors:  F Voulgaropoulou; B Tan; M Soares; B Hahn; L Ratner
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups.

Authors:  M T Dittmar; G Simmons; S Hibbitts; M O'Hare; S Louisirirotchanakul; S Beddows; J Weber; P R Clapham; R A Weiss
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations.

Authors:  S Günther; G Sommer; F Von Breunig; A Iwanska; T Kalinina; M Sterneck; H Will
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

5.  Distribution of HIV-1 infection in different T lymphocyte subsets: antiretroviral therapy-naïve vs. experienced patients.

Authors:  Raul Perez; Sonia Gibson; Pablo Lopez; Ellen Koenig; Marisol De Castro; Yasuhiro Yamamura
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-07       Impact factor: 2.205

6.  Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system.

Authors:  T H Wang; Y K Donaldson; R P Brettle; J E Bell; P Simmonds
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  Correlation between CD4 T cell counts and virus compartmentalization in genital and systemic compartments of HIV-infected females.

Authors:  Suman Chaudhary; Richard J Noel; Nayra Rodríguez; Santiago Collado; Jhoanne Munoz; Anil Kumar; Yashuhiro Yamamura
Journal:  Virology       Date:  2011-07-13       Impact factor: 3.616

8.  Association of human mannose receptor in sexual transmission of human immunodeficiency virus in serodiscordant couples.

Authors:  Shivaji K Jadhav; Shilpa M Velhal; Alaka Deshpande; Atmaram H Bandivdekar
Journal:  AIDS Res Hum Retroviruses       Date:  2013-01       Impact factor: 2.205

9.  Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?

Authors:  V Novitsky; U R Smith; P Gilbert; M F McLane; P Chigwedere; C Williamson; T Ndung'u; I Klein; S Y Chang; T Peter; I Thior; B T Foley; S Gaolekwe; N Rybak; S Gaseitsiwe; F Vannberg; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

10.  V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1.

Authors:  S Y Chan; R F Speck; C Power; S L Gaffen; B Chesebro; M A Goldsmith
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.